RAC 2.20% $1.78 race oncology ltd

STRONG SELL/ 50% downside potential, page-34

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    Will also add that claims that RAC’s patent position is weak are rubbish.

    The founders initiated a strong patent position before RAC listed. This has since been strengthened ( mainly through some of the patents now reaching granted status ).

    RAC will keep adding lines of patent defence as they see fit ( an additional 13 patents now filed for FTO ).
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.